Preclinical assessment of a novel small molecule inhibitor of tryptophan 2,3-dioxygenase 2 (TDO2)

Stefano Crosignani; Gregory Driessens; Michel Detheux; Benoît Van den Eynde; Sandra Cauwenberghs

doi:10.1186/2051-1426-2-S3-P196

Article info

PDF

Poster Presentation

Preclinical assessment of a novel small molecule inhibitor of tryptophan 2,3-dioxygenase 2 (TDO2)

Free

Authors

Stefano Crosignani iTeos Therapeutics Gosselies Belgium PubMed articles Google scholar articles
Gregory Driessens iTeos Therapeutics Gosselies Belgium PubMed articles Google scholar articles
Michel Detheux iTeos Therapeutics Gosselies Belgium PubMed articles Google scholar articles
Benoît Van den Eynde Ludwig Institute for Cancer Research (LICR, Brussels Branch) and de Duve InstituteUniversité catholique de Louvain (UCL) Brussels Belgium PubMed articles Google scholar articles
Sandra Cauwenberghs iTeos Therapeutics Gosselies Belgium PubMed articles Google scholar articles

Citation

Crosignani S, Driessens G, Detheux M, et al

Preclinical assessment of a novel small molecule inhibitor of tryptophan 2,3-dioxygenase 2 (TDO2)

Journal for ImmunoTherapy of Cancer 2014;2:P196. doi: 10.1186/2051-1426-2-S3-P196

Publication history

First published November 6, 2014.

Online issue publication

March 11, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password